HEBP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 8.44524450371864E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
8.4617979290158E-11 |
Normal-vs-Stage2 |
4.83320050648217E-11 |
Normal-vs-Stage3 |
1.63424829224823E-13 |
Normal-vs-Stage4 |
3.1807001477091E-11 |
Stage1-vs-Stage2 |
4.087000E-01 |
Stage1-vs-Stage3 |
1.141670E-03 |
Stage1-vs-Stage4 |
2.415800E-01 |
Stage2-vs-Stage3 |
1.064760E-01 |
Stage2-vs-Stage4 |
7.676400E-01 |
Stage3-vs-Stage4 |
2.580400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
7.69517782828189E-12 |
Normal-vs-AfricanAmerican |
8.18500001109612E-09 |
Normal-vs-Asian |
3.74290000000332E-05 |
Caucasian-vs-AfricanAmerican |
3.543000E-01 |
Caucasian-vs-Asian |
3.486000E-01 |
AfricanAmerican-vs-Asian |
2.888200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.9409365487918E-12 |
Normal-vs-Female |
5.33639799016328E-11 |
Male-vs-Female |
1.801010E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.82399999998562E-06 |
Normal-vs-Age(41-60Yrs) |
6.53110898696241E-12 |
Normal-vs-Age(61-80Yrs) |
1.17380549724544E-11 |
Normal-vs-Age(81-100Yrs) |
2.47270000031108E-08 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.512000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.591600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.666800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.393200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.502000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.418200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
6.10249999977164E-07 |
Normal-vs-Grade 2 |
4.98699970208349E-11 |
Normal-vs-Grade 3 |
2.78410627885251E-12 |
Normal-vs-Grade 4 |
1.06790021270342E-10 |
Grade 1-vs-Grade 2 |
8.883200E-01 |
Grade 1-vs-Grade 3 |
3.878800E-01 |
Grade 1-vs-Grade 4 |
6.944000E-01 |
Grade 2-vs-Grade 3 |
2.636500E-02 |
Grade 2-vs-Grade 4 |
5.197400E-01 |
Grade 3-vs-Grade 4 |
4.508800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
4.24826840372816E-12 |
Normal-vs-ccB subtype |
2.06969996696671E-10 |
ccA subtype-vs-ccB subtype |
6.821800E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
8.73134897716454E-12 |
Normal-vs-N1 |
3.155100E-03 |
N0-vs-N1 |
4.046800E-01 |
|
|